Aviva
GKOS icon

Aviva’s Glaukos GKOS Stock Holding History

Aviva’s Portfolio GKOS Stock Details GKOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-29,978
Closed -$1.63M – 959
2019
Q4 		$1.63M Buy
+29,978
New +$1.82M 0.01% 848

Other funds holding GKOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Aviva's GKOS Position: Q1 2020 in Review

Aviva sold out of Glaukos (GKOS) in Q1 2020, closing a stake of 29,978 shares — an estimated $1.63M sold.

Aviva first reported a position in GKOS in Q4 2019 and held it in 1 quarter. The position peaked at $1.63M in Q4 2019. 165 funds tracked by Wall St. Rank hold GKOS as of Q1 2020.

  • Aviva reported no remaining Glaukos position as of Q1 2020 after selling out during the quarter.
  • Aviva sold 29,978 Glaukos shares in Q1 2020, an estimated $1.63M.
  • Aviva first reported a position in Glaukos in Q4 2019 and held it in 1 quarter.
  • Aviva's Glaukos position peaked at $1.63M in Q4 2019.
  • 165 funds tracked by Wall St. Rank held Glaukos as of Q1 2020.

Based on Aviva's 13F filing for Q1 2020, filed 14 May 2020.